USD22.53
https://uae.pharmalabglobal.com/wp-content/uploads/2022/09/Ipamorelin-CJC-1295-no-DAC-Nasal-Peptide-Blend-15ml-300x300.jpeg Size:3-Month Supply Immune checkpoint inhibitor treatment HR+/HER2− breast cancer, the most prevalent subtype, exhibits limited sensitivity to neoadjuvant chemotherapy, with a pCR rate of ~10% qc GHK-Cu 100mg
USD22.53
USD25.91
USD21.77
USD25.95
USD23.81
USD25.85
USD21.43